Anúncio
Anúncio

ARMP

ARMP logo

Armata Pharmaceuticals, Inc. Common Stock

7.00
USD
Patrocinado
-0.89
-11.23%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

6.88

-0.13
-1.84%

Relatórios de Lucros ARMP

Rácio de surpresa positiva

ARMP separação 20 de 38 últimas estimativas.

53%

Próximo Relatório

Data do Próximo Relatório
18 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.53M
/
-$0.19
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+32.01%
/
-74.32%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+23.89%
/
-371.43%

Armata Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On 12 de nov. de 2025, ARMP reported earnings of -0.74 USD per share (EPS) for Q3 25, missing the estimate of -0.42 USD, resulting in a -72.74% surprise. Revenue reached 1.16 milhão, compared to an expected 1.41 milhão, with a -17.66% difference. The market reacted with a -4.63% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.19 USD, with revenue projected to reach 1.53 milhão USD, implying an diminuir of -74.32% EPS, and aumentar of 32.01% in Revenue from the last quarter.
FAQ
For Q3 2025, Armata Pharmaceuticals, Inc. Common Stock reported EPS of -$0.74, missing estimates by -72.74%, and revenue of $1.16M, -17.66% below expectations.
The stock price moved down -4.63%, changed from $6.69 before the earnings release to $6.38 the day after.
The next earning report is scheduled for 18 de mar. de 2026.
Based on 3 analistas, Armata Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.19 and revenue of $1.53M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio